Society guideline links: HIV infection in adolescents

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: HIV infection in infants and children" and "Society guideline links: HIV screening and diagnostic testing" and "Society guideline links: HIV prevention" and "Society guideline links: HIV treatment in nonpregnant adults and adolescents" and "Society guideline links: HIV treatment in pregnant women".)

International

●World Health Organization (WHO): Guidelines for managing advanced HIV disease and rapid initiation of antiretroviral therapy (2017)

●WHO: Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection – Recommendations for a public health approach, second edition (2016)

●WHO: HIV and adolescents – Guidance for HIV testing and counselling and care for adolescents living with HIV (2013)

Canada

●Public Health Agency of Canada (PHAC): Canadian guidelines on sexually transmitted infections (2019)

●Canadian Paediatric Society (CPS): Practice point on sexually transmitted infections in adolescents – Maximizing opportunities for optimal care (2014, updated 2018)

●Choosing Wisely Canada: Don't routinely repeat CD4 measurements in patients with HIV infection with HIV-1 RNA suppression for >2 years and CD4 counts >500/mcL, unless virologic failure occurs or intercurrent opportunistic infection develops (2017)

●PHAC: Human immunodeficiency virus – HIV screening and testing guide (2014)

United States

●Centers for Disease Control and Prevention (CDC): HIV/AIDS – Guidelines and recommendations

•HIV testing – Guidelines

•Persons with HIV – Prevention and care: Guidelines

•Preventing new HIV infections – Guidelines

●Department of Health and Human Services (DHHS): HIV/AIDS guidelines

•Guidelines for the prevention and treatment of opportunistic infections in adults and adolescents with HIV (updated 2021)

•Guidelines for the use of antiretroviral agents in adults and adolescents with HIV (updated 2021)

•Recommendations for use of antiretroviral drugs in pregnant women with HIV infection and interventions to reduce perinatal HIV transmission in the United States (updated 2021)

•Guidance for non-HIV-specialized providers caring for persons with HIV who have been displaced by disasters (such as a hurricane) (updated 2018)

●American Academy of Pediatrics (AAP): Red Book (2021)

•Bloodborne pathogens

•Consideration for testing for infectious agents

•Human immunodeficiency virus infection

•Sexually transmitted infections in adolescents and children

●CDC: Sexually transmitted diseases treatment guidelines – HIV infection: Detection, counseling, and referral (2021)

●HIVMA of the IDSA: Primary care guidance for persons with human immunodeficiency virus, update (2020)

●US Preventive Services Task Force (USPSTF): Final recommendation statement on human immunodeficiency virus (HIV) infection – Screening (2019)

●Society for Adolescent Health and Medicine (SAHM): Position paper on HIV pre-exposure prophylaxis medication for adolescents and young adults (2018)

●AAP: Policy statement on transitioning HIV-infected youth into adult health care (2013, reaffirmed 2016)

●Choosing Wisely: Avoid quarterly viral load testing of patients who have durable viral suppression, unless clinically indicated (2016)

●Choosing Wisely: Avoid unnecessary CD4 tests (2016)

●Choosing Wisely: Don't order complex lymphocyte panels when ordering CD4 counts (2016)

●Choosing Wisely: Don't routinely order testing for glucose-6-phosphate dehydrogenase (G6PD) deficiency for patients who are not predisposed due to race/ethnicity (2016)

●Choosing Wisely: Don't routinely test for CMV IgG in HIV-infected patients who have a high likelihood of being infected with CMV (2016)

●SAHM: Position paper on HIV infection and AIDS in adolescents, update (2006)

United Kingdom

●British HIV Association (BHIVA): Current guidelines

●British Association for Sexual Health and HIV (BASHH)/Expert Advisory Group on AIDS (EAGA): Statement on HIV window period (2014)

Australia-New Zealand

●Australasian Society for HIV Medicine (ASHM): Antiretroviral guidelines – Adolescents and young adults with HIV (2018)